Month: February 2024

Accepted for Presentation at the 2024 International Stroke Conference PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine that addresses the high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (aSAH), today announced that a poster outlining its pivotal Phase 3 STRIVE-ON safety trial (the STRIVE-ON trial–NCT05995405) has been accepted for presentation at the 2024 International Stroke Conference, to be held February 7-9, 2024 in Phoenix, AZ. The poster, Safety and Tolerability of Intravenous Versus Enteral Nimodipine in Patients with Aneurysmal Subarachnoid Hemorrhage, will be presented Thursday February 8th during the Ongoing Clinical Trials session of the conference. The...

TruContact Solution Honored for Third Consecutive Year in Telco Innovation Security & Fraud Category CHICAGO, Feb. 01, 2024 (GLOBE NEWSWIRE) — TransUnion announced today it has been named a winner in Juniper Research’s Future Digital Awards for Telco Innovation 2024 for the third year in a row. TruContact™ Spoofed Call Protection received a Gold Award for “Best Robocall Mitigation Solution” in the Security and Fraud Innovation category. Spoofed Call Protection (SCP) enables enterprises to digitally sign their outbound calls, helping to ensure calls aren’t being spoofed or mis-tagged as spam, so customers know and trust who’s calling, and are much more likely to answer the phone. Part of the Trusted Call Solution (TCS) suite, with SCP, spoofed calls can be blocked so they never reach consumers — helping to ensure...

New contract adds to Evtec’s existing order book of $780 million Parts supplied by Evtec to be used in new Jaguar Electric Vehicles to be introduced in 2025 DALLAS, Feb. 01, 2024 (GLOBE NEWSWIRE) — Blackboxstocks Inc. (NASDAQ: BLBX) (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders, announced today that its planned acquisition target Evtec Aluminium Limited, (“Evtec”) has been awarded a long term supply contract from JLR, previously Jaguar Land Rover, to supply parts for a new line of Jaguar electric vehicles. As a world class manufacturer of lightweight aluminum parts for the EV, luxury and performance automotive market, Evtec has been designated as the new single-source supplier for key components in the EV power train...

WARRINGTON, Pa., Feb. 01, 2024 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for critical cardiovascular disorders, today announced that it has renewed its partnership with Chang Gung University in Taiwan to further research on SERCA2a, an important target for the Company’s cardiovascular portfolio. Windtree personnel from its offices in Taipei, Taiwan will participate in the collaboration. The scientific collaboration includes the Company’s lead product candidate istaroxime and the next generation compounds called SERCA2a activators. One of istaroxime’s mechanisms of action is facilitation of myocardial relaxation through activation of the SERCA2a calcium pump on the sarcoplasmic reticulum enhancing calcium reuptake...

BOCA RATON, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) —  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that Samuel O’Rear will not stand for reelection to the Company’s Board of Directors at the Company’s 2024 annual meeting of stockholders.  Mr. O’Rear has been a Director of Sensus Healthcare since 2012. As previously announced, on January 11, 2024 the Board of Directors of Sensus Healthcare appointed Michael J. Sardano, President and General Counsel of Sensus Healthcare, as a Director, effective today. “Sam has been invaluable to the Board and to me personally since the inception of Sensus Healthcare more than a decade ago.  I wish him the same success in his...

SOUTH SAN FRANCISCO, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for the treatment of neurodegenerative diseases and lysosomal storage diseases, today announced upcoming presentations from its Enzyme Transport Vehicle (ETV) development programs, tividenofusp alfa (DNL310) and DNL126 (ETV:SGSH), to be given at the 20th Annual WORLDSymposium™, which will be held February 4-9, 2024, in San Diego, California. WORLDSymposium™ Presentation Details on DNL310 and DNL126 Presentations on DNL310 will include new two-year data on clinical outcomes and previously presented data on biomarkers from the ongoing Phase 1/2 study in MPS II. In addition, an oral presentation...

~ Attendees Invited to Visit Integer at Booth #1439 ~ PLANO, Texas, Feb. 01, 2024 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR), a leader in medical device outsource manufacturing, will join innovators and industry leaders around the world in exhibiting at MD&M West, Feb. 6-8, 2024, at the Anaheim Convention Center in Anaheim, California. Integer welcomes visitors to booth #1439 to learn more about the company’s unwavering commitment to customers as their partner of choice in enhancing the lives of patients through access to Integer’s innovative technology, superior quality and dependable manufacturing to accelerate speed to market and reduce development risk. Integer’s exhibit will spotlight the recent strategic acquisitions of InNeuroCo and Pulse Technologies, each of which have further enhanced Integer’s...

SÃO PAULO, Brazil, Feb. 01, 2024 (GLOBE NEWSWIRE) — Semantix, Inc. (“Semantix” or “the Company”) (NASDAQ: STIX), a leading Latin American enterprise AI platform and applications provider, announced the initiation of a strategic partnership with SPC Grafeno – a financial asset registrar established through a joint venture between Grafeno and SPC Brazil. The collaboration was unveiled during an exclusive event featuring representatives from both organizations, signaling a joint effort to bring positive changes to Brazil’s credit market. The partnership aims to position SPC Grafeno as a data intelligence infrastructure in the financial market, leveraging the Semantix stack to expedite product creation, refine data processing, and enhance storage strategies. By introducing financial assets as influential players in credit...

New offerings will help organizations and learners close skills gaps faster and drive better learning outcomes SAN FRANCISCO, Feb. 01, 2024 (GLOBE NEWSWIRE) — Udemy (Nasdaq: UDMY), a leading online skills marketplace and learning platform, today announced a series of generative AI (gen AI)-enabled offerings designed to support personalized learning and enhanced skills development. The comprehensive Udemy Intelligent Skills Platform will include Udemy AI Learning Assistant, Udemy AI Skills Mapping and several new enhancements for content creators/instructors, such as a gen AI-assisted Q&A feature. “We believe gen AI is radically revolutionizing the way we work and how professionals are developing new skills,” said Greg Brown, President and Chief Executive Officer at Udemy. “As the world transitions to a skills-based economy,...

CALGARY, Alberta, Feb. 01, 2024 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE) (TSX:GTE) (LSE:GTE) today announced that it intends, subject to market and other conditions, to offer an additional amount of its previously issued 9.500% Senior Secured Amortizing Notes due 2029 (the “Notes”) in a private placement to persons reasonably believed to be qualified institutional buyers in the United States pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), to non-U.S. persons in transactions outside the United States pursuant to Regulation S under the Securities Act, and pursuant to certain prospectus exemptions in Canada. Gran Tierra currently has outstanding US$487,590,000 aggregate principal amount of 9.500% Senior Secured Amortizing Notes due 2029...